サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1787231

神経血管塞栓装置の世界市場

Neurovascular Embolization Devices

出版日
ページ情報
英文 284 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
神経血管塞栓装置の世界市場
出版日: 2025年08月08日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 284 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

神経血管塞栓装置の世界市場は2030年までに15億米ドルに達する

2024年に12億米ドルと推定される神経血管塞栓装置の世界市場は、分析期間2024-2030年にCAGR 4.6%で成長し、2030年には15億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである塞栓コイルは、CAGR 3.6%を記録し、分析期間終了時には5億7,960万米ドルに達すると予測されています。血流転換装置セグメントの成長率は、分析期間中CAGR 3.8％と推定されます。

米国市場は3億1,540万米ドルと推定、中国はCAGR7.1％で成長予測

米国の神経血管塞栓装置市場は、2024年に3億1,540万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを7.1%として、2030年までに2億9,400万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.2%と4.6%と予測されています。欧州では、ドイツがCAGR 2.9%で成長すると予測されています。

世界の神経血管塞栓装置市場- 主要動向と促進要因のまとめ

なぜ神経血管塞栓装置は脳卒中や動脈瘤の治療に不可欠なのか？

神経血管塞栓装置は、頭蓋内動脈瘤、動静脈奇形（AVM）、その他の脳血管異常の管理において重要な存在となっています。塞栓コイル、液体塞栓剤、フローダイバータ、血管プラグなどの低侵襲デバイスは、動脈瘤の破裂を予防し、異常血管への血流を減少させ、脳循環を安定させるように設計されています。脳卒中や出血性疾患が世界的に障害や死亡の主要な原因となっていることから、神経血管塞栓術は開頭術やクリッピング術といった従来の外科的介入に代わる効果的な方法として注目を集めています。血管内治療の進歩は患者の予後を著しく改善し、回復に要する時間や治療後の合併症を減少させています。特にflow divertersは、以前は手術不可能と考えられていた頚部の広い複雑な動脈瘤を治療するための画期的な技術として登場しました。さらに、液体塞栓剤は血管を正確に閉塞させ、出血の再発リスクを軽減することにより、AVM治療に革命をもたらしています。神経血管疾患の世界の負担が増加するにつれて、塞栓装置の需要は増加し、神経インターベンション治療におけるさらなる技術革新と採用が促進されています。

神経血管塞栓装置の採用を妨げる課題とは？

神経血管塞栓装置の有効性は証明されていますが、いくつかの課題が神経血管塞栓装置の普及を妨げています。主な懸念事項の一つは、血管内塞栓術の費用が高く、ヘルスケア資金が限られている地域では利用しにくいことです。さらに、塞栓術は技術的に複雑であるため、高度な訓練を受けた神経インターベンション専門医が必要であり、地方や未発達のヘルスケアシステムでは利用が制限されています。もう一つの大きな課題は、血管穿孔、虚血、塞栓物質の移動を含む手技合併症のリスクであり、これらは脳卒中や神経障害を引き起こす可能性があります。また、患者の解剖学的構造や血管の状態にばらつきがあるため、個々に合わせた治療計画が必要となり、高度な画像診断や広範な手技前評価が必要となります。新しい塞栓技術に対する規制上のハードルと長い承認サイクルは、市場の拡大をさらに遅らせ、次世代の神経血管治療へのアクセスを遅らせています。さらに、低侵襲神経血管インターベンションに対する患者の意識は依然として低く、診断の遅れや塞栓療法の利用不足につながっています。これらの課題に対処するためには、医師のトレーニングへの投資拡大、機器の安全性と精度の向上、塞栓術をより広く利用できるようにするための努力の強化が必要であり、そのためには手頃な価格のものが必要です。

技術革新はどのように神経血管塞栓装置の効果を高めているか？

神経血管塞栓術の分野では、手技の成功率を向上させ、複雑な脳血管疾患に対する治療の選択肢を広げる急速な技術進歩が見られます。最も重要な技術革新の一つは、生物活性塞栓コイルの開発です。このコイルは、内皮細胞の増殖を促進することにより、動脈瘤の閉塞を早め、長期的な血管の治癒を促進します。さらに、柔軟性と流量調節機能を向上させた第2世代のフローダイバータの導入により、大型で頚部の広い動脈瘤に対する治療の安全性と有効性が向上しています。AIを駆使した画像診断とロボット支援による血管内ナビゲーションの統合は、正確な塞栓術を可能にし、合併症のリスクを最小限に抑え、患者の転帰を改善しています。粘度制御を強化した液体塞栓剤もまた、標的血管構造への浸透性と接着性を向上させることで、AVM治療を前進させています。さらに、塞栓療法後に神経保護薬理学的介入を行うような併用療法の出現は、神経血管治療戦略をさらに最適化しています。機器メーカーが塞栓技術を改良し続けているため、神経インターベンション治療はより安全で効率的なものとなり、より多くの患者が利用できるようになってきています。

神経血管塞栓装置市場の成長の原動力は？

神経血管塞栓装置市場の成長は、脳血管疾患の有病率の上昇、低侵襲手技の採用の増加、血管内治療技術の継続的な進歩など、いくつかの要因によって牽引されています。頭蓋内動脈瘤やAVMの発生率の増加は、人口の高齢化や高血圧、喫煙などの生活習慣に関連する危険因子に後押しされ、効果的な神経血管インターベンションに対する強い需要を生み出しています。塞栓術は開頭手術に比べて罹患率が低く、入院期間も短いため、低侵襲技術へのシフトが市場拡大をさらに加速しています。生体吸収性塞栓剤や放射線不透過性塞栓剤を含む塞栓材料の技術的進歩は、手技の精度と安全性を高めています。さらに、3D回転血管造影や灌流MRIなどの高度な神経画像技術が利用可能になりつつあることも、診断や治療計画を向上させ、採用率を高める原動力となっています。脳卒中治療のインフラ整備を目的とした償還政策の拡大や政府の取り組みも、市場成長に重要な役割を果たしています。ヘルスケアプロバイダーや研究機関が神経血管イノベーションへの投資を続けていることから、複雑な脳血管疾患を抱える患者に救命ソリューションを提供する神経血管塞栓装置市場は大幅な拡大が見込まれています。

セグメント

製品タイプ（塞栓コイル、血流転換装置、液体塞栓剤、動脈瘤クリップ）、エンドユーザー（病院エンドユーザー、専門クリニックエンドユーザー、その他エンドユーザー）

調査対象企業の例

  • Abbott Laboratories
  • Acandis GmbH
  • ASAHI INTECC CO., LTD.
  • B. Braun Melsungen AG
  • Balt SAS
  • Cerus Endovascular
  • Imperative Care
  • Integer Holdings Corporation
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.（CERENOVUS）
  • Medikit Co., Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • MicroVention, Inc.（Terumo Corporation）
  • Penumbra, Inc.
  • Perflow Medical Ltd.
  • Phenox GmbH
  • Shape Memory Medical
  • Stryker Corporation

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP32332

Global Neurovascular Embolization Devices Market to Reach US$1.5 Billion by 2030

The global market for Neurovascular Embolization Devices estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Embolic Coils, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$579.6 Million by the end of the analysis period. Growth in the Flow Diversion Devices segment is estimated at 3.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$315.4 Million While China is Forecast to Grow at 7.1% CAGR

The Neurovascular Embolization Devices market in the U.S. is estimated at US$315.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$294.0 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global Neurovascular Embolization Devices Market - Key Trends & Drivers Summarized

Why Are Neurovascular Embolization Devices Essential in Stroke and Aneurysm Treatment?

Neurovascular embolization devices have become critical in the management of intracranial aneurysms, arteriovenous malformations (AVMs), and other cerebrovascular abnormalities. These minimally invasive devices, including embolic coils, liquid embolic agents, flow diverters, and vascular plugs, are designed to prevent aneurysm rupture, reduce blood flow to abnormal vessels, and stabilize cerebral circulation. With stroke and hemorrhagic conditions being leading causes of disability and mortality worldwide, neurovascular embolization procedures are gaining traction as an effective alternative to traditional surgical interventions such as craniotomy and clipping. The advancement of endovascular techniques has significantly improved patient outcomes, reducing recovery times and post-procedural complications. In particular, flow diverters have emerged as a game-changing technology for treating wide-necked and complex aneurysms that were previously considered inoperable. Additionally, liquid embolic agents are revolutionizing AVM treatment by allowing precise vessel occlusion, reducing the risk of recurrent hemorrhage. As the global burden of neurovascular diseases rises, the demand for embolization devices is increasing, driving further innovation and adoption in neurointerventional procedures.

What Challenges Are Hindering the Adoption of Neurovascular Embolization Devices?

Despite their proven efficacy, several challenges hinder the widespread adoption of neurovascular embolization devices. One of the primary concerns is the high cost of endovascular embolization procedures, making them less accessible in regions with limited healthcare funding. Additionally, the technical complexity of embolization procedures requires highly trained neurointerventionalists, limiting availability in rural and underdeveloped healthcare systems. Another significant challenge is the risk of procedural complications, including vessel perforation, ischemia, and migration of embolic materials, which can lead to stroke or neurological deficits. The variability in patient anatomy and vascular conditions also necessitates personalized treatment planning, requiring advanced imaging and extensive pre-procedural evaluation. Regulatory hurdles and long approval cycles for new embolization technologies further slow down market expansion, delaying access to next-generation neurovascular treatments. Moreover, patient awareness about minimally invasive neurovascular interventions remains low, leading to delayed diagnosis and underutilization of embolization therapies. Addressing these challenges will require greater investment in physician training, improvements in device safety and precision, and increased efforts to make embolization procedures more widely available and affordable.

How Are Innovations Enhancing the Effectiveness of Neurovascular Embolization Devices?

The field of neurovascular embolization is witnessing rapid technological advancements that are improving procedural success rates and expanding treatment options for complex cerebrovascular conditions. One of the most significant innovations is the development of bioactive embolic coils, which promote faster aneurysm occlusion and long-term vessel healing by encouraging endothelial cell growth. Additionally, the introduction of second-generation flow diverters with improved flexibility and flow modulation capabilities is enhancing treatment safety and effectiveness for large and wide-necked aneurysms. The integration of AI-powered imaging and robotic-assisted endovascular navigation is enabling precise embolization procedures, minimizing the risk of complications and improving patient outcomes. Liquid embolic agents with enhanced viscosity control are also advancing AVM treatment by providing better penetration and adhesion to targeted vascular structures. Moreover, the emergence of combination therapies-such as embolization followed by neuroprotective pharmacological interventions-is further optimizing neurovascular treatment strategies. As device manufacturers continue to refine embolization technologies, neurointerventional procedures are becoming safer, more efficient, and accessible to a broader patient population.

What Is Driving the Growth of the Neurovascular Embolization Devices Market?

The growth in the neurovascular embolization devices market is driven by several factors, including the rising prevalence of cerebrovascular diseases, increasing adoption of minimally invasive procedures, and continuous advancements in endovascular technology. The growing incidence of intracranial aneurysms and AVMs, fueled by aging populations and lifestyle-related risk factors such as hypertension and smoking, is creating a strong demand for effective neurovascular interventions. The shift toward minimally invasive techniques is further accelerating market expansion, as embolization procedures offer lower morbidity and shorter hospital stays compared to open surgeries. Technological advancements in embolization materials, including bioresorbable and radiopaque embolic agents, are enhancing procedural precision and safety. Additionally, the increasing availability of advanced neuroimaging techniques, such as 3D rotational angiography and perfusion MRI, is improving diagnosis and treatment planning, driving higher adoption rates. Expanding reimbursement policies and government initiatives aimed at improving stroke care infrastructure are also playing a crucial role in market growth. As healthcare providers and research institutions continue to invest in neurovascular innovation, the neurovascular embolization devices market is poised for substantial expansion, offering life-saving solutions for patients with complex cerebrovascular conditions.

SCOPE OF STUDY:

The report analyzes the Neurovascular Embolization Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents, Aneurysm Clips); End-Use (Hospitals End-Use, Specialty Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • Acandis GmbH
  • ASAHI INTECC CO., LTD.
  • B. Braun Melsungen AG
  • Balt SAS
  • Cerus Endovascular
  • Imperative Care
  • Integer Holdings Corporation
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc. (CERENOVUS)
  • Medikit Co., Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • MicroVention, Inc. (Terumo Corporation)
  • Penumbra, Inc.
  • Perflow Medical Ltd.
  • Phenox GmbH
  • Shape Memory Medical
  • Stryker Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Neurovascular Embolization Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Aneurysms and Stroke Cases Throws the Spotlight on Neurovascular Embolization Devices
    • Increasing Geriatric Population Base Globally Spurs Demand for Minimally Invasive Neurovascular Interventions
    • Technological Advancements in Detachable Coils and Liquid Embolic Agents Propel Market Growth
    • Development of Bioresorbable and Next-Generation Embolic Materials Expands Addressable Market Opportunity
    • Integration of AI and Image-Guided Navigation in Neurovascular Procedures Strengthens Business Case for Device Innovation
    • Growing Physician Preference for Endovascular Over Open Neurosurgery Drives Adoption of Embolization Devices
    • Government-Led Stroke Awareness Campaigns Accelerate Demand for Early Diagnosis and Intervention Tools
    • Rising Healthcare Spending in Emerging Markets Unlocks New Revenue Pools for Neurovascular Device Manufacturers
    • Increasing Hospital Investments in Hybrid Operating Rooms Creates Favorable Ecosystem for Advanced Embolization Devices
    • Surge in Interventional Neuroradiology Training Programs Sustains Growth in Skilled Workforce and Procedure Volumes
    • Rapid Shift Towards Outpatient and Ambulatory Neurosurgical Centers Spurs Demand for Compact and Easy-to-Use Devices
    • Ongoing Clinical Trials and Evidence-Based Approvals Strengthen Regulatory Confidence and Propel Commercial Uptake
    • Strategic Collaborations Between Device Companies and Academic Research Institutions Drive Innovation Pipeline
    • Increasing Reimbursement Coverage for Neurovascular Interventions Bolsters Market Accessibility and Uptake
    • Emergence of Flow Diversion Techniques as Adjunct to Embolization Expands Treatment Landscape
    • Rising Demand for Personalized Medicine Approaches Drives Interest in Customized Embolic Therapies
    • Growing Concerns Around Device Safety and Adverse Events Pose Regulatory Challenges and Slow Down Approvals
    • Increasing Use of Big Data and Predictive Analytics in Treatment Planning Enhances Clinical Outcomes and Device Use
    • Expansion of Tele-Neurointervention Capabilities in Remote Areas Propels Demand for Portable Embolization Systems
    • Advancements in 3D Printing of Neurovascular Models Facilitate Physician Training and Drive Confidence in Device Usage
    • Intensifying Competition Among Market Players Drives Pricing Pressures but Also Fuels Innovation in Product Differentiation
    • Regulatory Harmonization Across Key Markets Reduces Time-to-Market and Supports Global Expansion of Embolization Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neurovascular Embolization Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neurovascular Embolization Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Neurovascular Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Embolic Coils by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Embolic Coils by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Embolic Coils by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Flow Diversion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Flow Diversion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Flow Diversion Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Liquid Embolic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Liquid Embolic Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Liquid Embolic Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Aneurysm Clips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Aneurysm Clips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Aneurysm Clips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Neurovascular Embolization Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Neurovascular Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Neurovascular Embolization Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Neurovascular Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Neurovascular Embolization Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Neurovascular Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Neurovascular Embolization Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Neurovascular Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Neurovascular Embolization Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Neurovascular Embolization Devices by Product Type - Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Neurovascular Embolization Devices by Product Type - Percentage Breakdown of Value Sales for Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents and Aneurysm Clips for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Neurovascular Embolization Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Neurovascular Embolization Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION